James River Group Holdings, Inc. annual report, FY2015

完整文档

Business context and reporting period

James River Group Holdings, Ltd. filed this Form 10-K for the fiscal year ended December 31, 2015. The Bermuda-based insurance holding company operates Excess and Surplus Lines, Specialty Admitted Insurance, and Casualty Reinsurance businesses, plus Corporate and Other. About 98% of 2015 group-wide gross written premiums came from casualty insurance and reinsurance; 73% originated in the U.S. excess and surplus market.

Key financial results

  • Premiums and revenue: Gross written premiums rose 10.3% to $572.2 million; net written premiums increased 4.7% to $471.0 million; net earned premiums increased 16.4% to $461.2 million. Total revenue was $504.9 million.
  • Profit: Net income was $53.5 million, up 19.7%, and diluted EPS was $1.82 versus $1.55. Non-GAAP net operating income was $61.1 million, up 4.6%. Underwriting profit increased 3.4% to $27.6 million.
  • Underwriting and margins: The consolidated combined ratio was 94.0%, compared with 93.3% in 2014; below 100% generally indicates an underwriting profit. The loss ratio was 60.5% and expense ratio 33.5%. The 2015 combined ratio included $16.3 million of favorable prior-year reserve development, or 3.5 percentage points.
  • Segments: Excess and Surplus Lines underwriting profit increased to $47.6 million, with an 80.2% combined ratio. Specialty Admitted Insurance earned $1.1 million of underwriting profit and had a 97.5% combined ratio. Casualty Reinsurance recorded a $2.6 million underwriting loss and a 101.4% combined ratio.
  • Investments: Net investment income increased 4.3% to $44.8 million. Net realized investment losses were $4.5 million, compared with $1.3 million in 2014, including $3.9 million of impairment losses on two energy-sector loans. Other comprehensive income was a loss of $15.2 million.
  • Cash flow and liquidity: Operating cash flow was $116.4 million, versus $130.4 million. Cash and invested assets totaled $1.351 billion at year-end, including $106.4 million of cash and cash equivalents and $1.244 billion of invested assets. Total assets were $2.055 billion; shareholders’ equity was $681.0 million.
  • Debt and capital: Balance-sheet senior debt was $88.3 million and junior subordinated debt was $104.1 million. The company also had $73.3 million drawn on its unsecured revolving facility and $35.1 million of letters of credit issued under its secured facility. Debt to total capitalization was 22.0%, versus 21.9%. U.S. insurance subsidiaries reported $176.9 million of statutory capital and surplus; JRG Re reported $357.7 million of statutory capital and surplus.
  • Reserves: Gross loss and loss adjustment expense reserves were $785.3 million and net reserves were $653.5 million; 68.0% of each was IBNR. Prior-year development was favorable by $25.4 million in Excess and Surplus Lines and $3.5 million in Specialty Admitted Insurance, partly offset by $12.6 million adverse development in Casualty Reinsurance.

Material changes versus 2014

  • Excess and Surplus Lines gross written premiums grew 22.2%; Specialty Admitted Insurance grew 53.2%, led by program and fronting business; Casualty Reinsurance premiums declined 16.5% amid intense competition.
  • Program and fronting premiums in Specialty Admitted Insurance rose to $55.0 million gross ($12.4 million net). The segment’s net retention fell to 49.4%, largely because these newer businesses are substantially reinsured.
  • Combined ratio deterioration reflected a higher consolidated loss ratio and lower favorable reserve development than in 2014. Casualty Reinsurance shifted from a $0.7 million underwriting profit to a $2.6 million loss.
  • Cash and invested assets increased 3.1%, while tangible equity declined from $466.0 million to $459.7 million. Management said tangible equity would have grown 8.9% absent $47.8 million of 2015 dividends.
  • Investment results faced greater energy-sector pressure: the company recorded $3.9 million of energy-loan impairments and sold some energy loans. The duration of the investment portfolio rose from 3.1 to 3.5 years.

Outlook, management commentary, risks and unusual items

  • Management’s stated priorities are consistent underwriting profitability, balance-sheet strength, active capital management, and measured growth in specialty markets. It reported stable rates and benign loss trends in key U.S. primary segments, but acknowledged softening rates and competition in parts of the market.
  • Management expects program and fronting fee income to become material and to provide a steadier revenue stream; it also expects Specialty Admitted Insurance’s expense ratio to decline as the business scales. These are expectations, not quantified guidance.
  • The A.M. Best financial strength rating was A- (Excellent), with a positive outlook. The company estimated group-wide pre-tax loss from a 1-in-1,000-year catastrophe event at no more than $10 million, inclusive of reinstatement premiums.
  • Key risks include uncertain long-tail casualty reserves, catastrophe exposure, reinsurance counterparty and fronting collateral risk, dependence on a concentrated group of brokers and cedents, underwriting-cycle shifts, and investment credit and interest-rate risk. A 1% rate increase was estimated to reduce portfolio market value by about $43.3 million before tax.
  • Reserve sensitivity analysis showed a carried net reserve of $653.5 million against a modeled 95th-percentile outcome of $714.2 million; recording that higher estimate would reduce after-tax income and equity by about $52.1 million. The filing emphasizes that reserve estimates are inherently uncertain.
  • Unusual items included $4.5 million of realized investment losses, the $2.5 million U.S. dividend withholding tax on an intercompany distribution, and $47.8 million of shareholder dividends, including a $1.00-per-share special dividend. The 2014 comparison included $14.9 million of IPO-related expenses.
  • Related-party investment exposures include renewable-energy investments managed by an affiliate of a principal shareholder and a $4.5 million subordinated note issued by a bank holding company associated with the CEO. Management reported no material legal proceedings and no material goodwill impairment.

Most important facts for investors to verify

  1. Whether reserve development remains favorable, particularly in Excess and Surplus Lines, and whether Casualty Reinsurance’s adverse development persists.
  2. Whether growth in program and fronting business produces the anticipated fee income and improved segment expense ratio, while maintaining adequate collateral and risk controls.
  3. The quality and concentration of investment exposures, especially energy loans, Puerto Rico-related holdings, below-investment-grade bank loans, and related-party investments.
  4. Revolver utilization, debt maturities and covenants, and the capacity of regulated subsidiaries to upstream dividends without impairing capital or ratings.
  5. Broker, agent, and cedent concentration; the filing reports material business dependence on a small number of distribution partners and reinsurance relationships.